Mutant p62P392L stimulation of osteoclast differentiation in Paget's disease of bone - Wikidata - wikimedia - TriplyDB

Mutant p62P392L stimulation of osteoclast differentiation in Paget's disease of bone

Mutant p62P392L stimulation of osteoclast differentiation in Paget's disease of bone

http://www.wikidata.org/entity/Q35416974

about

P62: An emerging oncotarget for osteolytic metastasis Pathobiology of Paget's Disease of Bone Alternative splicing in osteoclasts and Paget's disease of bone.SCFβ-TRCP regulates osteoclastogenesis via promoting CYLD ubiquitination.Genome-wide meta-analysis identifies 56 bone mineral density loci and reveals 14 loci associated with risk of fracture.Increased IL-6 expression in osteoclasts is necessary but not sufficient for the development of Paget's disease of bone.RNA-Seq and ChIP-Seq reveal SQSTM1/p62 as a key mediator of JunB suppression of NF-κB-dependent inflammation CYLD-mediated signaling and diseases.The adaptor protein p62/SQSTM1 in osteoclast signaling pathways.Sequestosome 1/p62: across diseases.Pathogenesis of Paget disease of bone.Diverse ubiquitin linkages regulate RIP kinases-mediated inflammatory and cell death signaling.Measles virus nucleocapsid protein modulates the Signal Regulatory Protein-β1 (SIRPβ1) to enhance osteoclast differentiation in Paget's disease of bone.p62/sequestosome 1 deficiency accelerates osteoclastogenesis in vitro and leads to Paget's disease-like bone phenotypes in mice.

P2860

Q26753091-93A69AB5-6774-4BFE-8449-FCD7C925E9B9 Q26824476-174F8862-EC0D-43B8-9362-C59CC49CAD13 Q34085047-D476FF19-E204-4D39-8225-730EF9DCDFDA Q34100910-8B352C8B-0E7D-4971-9F0D-E0813160C2EC Q34268288-713419B6-66AC-4763-BC85-D2C2A27D799B Q35180477-A69A89AF-1F2E-4016-93F1-A7EF1B772F06 Q35196307-E652450C-6618-4A9B-A651-FCFC5216129C Q35565726-BCE7F274-190A-45D6-A4BE-C589B05881F4 Q37973113-F1BE5D21-791D-4281-B91A-96D18FB28AFE Q37980487-E07C0D5C-8028-49FE-BA23-32B6813970AE Q38006389-7F2077EA-B849-4A14-8182-D35CC373C9E2 Q39285713-DB774649-A592-4BAB-8575-A8CF317F0CB2 Q40706062-5122317E-09A6-4921-8286-E64F864B0D4E Q55173910-C86B00DB-F9CD-4728-AF42-872D4A17D95C

P2860

Mutant p62P392L stimulation of osteoclast differentiation in Paget's disease of bone

http://www.wikidata.org/entity/Q35416974

description

2011 nî lūn-bûn

@nan

2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Mutant p62P392L stimulation of osteoclast differentiation in Paget's disease of bone

@ast

Mutant p62P392L stimulation of osteoclast differentiation in Paget's disease of bone

@en

type

label

Mutant p62P392L stimulation of osteoclast differentiation in Paget's disease of bone

@ast

Mutant p62P392L stimulation of osteoclast differentiation in Paget's disease of bone

@en

prefLabel

Mutant p62P392L stimulation of osteoclast differentiation in Paget's disease of bone

@ast

Mutant p62P392L stimulation of osteoclast differentiation in Paget's disease of bone

@en

P1433

Q35416974-F33F3A98-64CB-42DA-A531-A6D198C5F338

P1476

Q35416974-A5F33F63-3C13-43F9-B502-B435BAF5F2E9

P2093

Q35416974-661685BB-B17C-4C09-AE52-8EA2ED113A6E

Q35416974-7A77315F-F713-4F82-B0DB-EF497FAA18F7

Q35416974-A57014A9-0289-49E9-B416-B3686AD0FCF9

Q35416974-D6FABAA2-1AE9-4137-902F-952A8A6AEDF8

P2860

Q35416974-04D85E4C-CA1C-4A93-A828-61E66366E543

Q35416974-075430F2-D392-4D1E-AD4F-26F4A7740C19

Q35416974-0CC84777-7452-4D4B-A7C2-31377BB816AF

Q35416974-0F514BA1-EAEA-48EB-B1F9-3334609CDF42

Q35416974-156101FA-830C-4DD3-9A2A-97A88B2CC4F1

Q35416974-18A12C9C-D6B9-4684-B94C-A3ED1FC6DDC3

Q35416974-1D1DFC18-3944-4688-B547-CFA1A9479983

Q35416974-22EE6212-AD05-4BF4-9484-A3462E6D1C33

Q35416974-374C0BFA-7999-4FB0-9E7D-96672B972B8E

Q35416974-3F350E09-CC62-45B4-8F95-2A5F6A738329

P304

Q35416974-B70CA0E4-8915-446D-9C75-460DB8377A47

P31

Q35416974-EE7A95D8-0389-4FD3-B7C9-FD2013DA6492

P356

Q35416974-935C6317-45AA-4CD9-9D7D-58679EE375DA

P407

Q35416974-A11005BF-39B5-4DEF-8672-0EF398C9BDBB

P433

Q35416974-D888A2D9-3F9D-41C5-B501-F3D26505682F

P478

Q35416974-B8CDD0B0-0BC8-44D2-AC30-A5C0861BAC24

P577

Q35416974-614F4549-8E96-40D9-A67E-37119BBABD5F

P5875

Q35416974-648F2C51-B1D9-41A6-9135-341BCC345956

P698

Q35416974-41E98159-24C6-4848-8030-0EB636EA88DC

P932

Q35416974-420359AA-BEDF-48BF-AC49-5BE939DAAEA8

P356

P1433

P1476

Mutant p62P392L stimulation of osteoclast differentiation in Paget's disease of bone

@en

P2093

D Sudhaker Rao

http://www.w3.org/2001/XMLSchema#string

Kumaran Sundaram

http://www.w3.org/2001/XMLSchema#string

Sakamuri V Reddy

http://www.w3.org/2001/XMLSchema#string

Srinivasan Shanmugarajan

http://www.w3.org/2001/XMLSchema#string

P2860

Network organization of the human autophagy system

A method to identify p62’s UBA domain interacting proteins

Identification of the familial cylindromatosis tumour-suppressor gene

CYLD is a deubiquitinating enzyme that negatively regulates NF-kappaB activation by TNFR family members

Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-kappaB

The tumour suppressor CYLD negatively regulates NF-kappaB signalling by deubiquitination

Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems

Genetic regulation of osteoclast development and function

Somatic mutations in SQSTM1 detected in affected tissues from patients with sporadic Paget's disease of bone.

Sequence analysis of measles virus nucleocapsid transcripts in patients with Paget's disease.

P304

4180-4189

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1210/EN.2011-1225

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

152

http://www.w3.org/2001/XMLSchema#string

P577

2011-08-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51606319

http://www.w3.org/2001/XMLSchema#string

P698

21878516

http://www.w3.org/2001/XMLSchema#string

P932

3198995

http://www.w3.org/2001/XMLSchema#string